Patent details

EP3149480 Title: RISK-STRATIFICATION OF B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

Basic Information

Publication number:
EP3149480
PCT Application Number:
IB2015053705
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP157270729
PCT Publication Number:
WO2015181683
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
RISK-STRATIFICATION OF B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS
French Title of Invention:
STRATIFICATION DU RISQUE POUR PATIENTS SOUFFRANT DE LEUCÉMIE AIGUË LYMPHOBLASTIQUE À PRÉCURSEURS B
German Title of Invention:
RISIKOSTRATIFIZIERUNG VON PATIENTEN MIT AKUTER LYMPHATISCHER B-VORLÄUFER-LEUKÄMIE
SPC Number:

Dates

Filing date:
20/05/2015
Grant date:
26/12/2018
EP Publication Date:
05/04/2017
PCT Publication Date:
03/12/2015
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
26/12/2018
EP B1 Publication Date:
26/12/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
20/05/2035
Renunciation date:
Revocation date:
04/05/2021
Annulment date:

Owner

From:
19/12/2018
 
 

Name:
Amgen Inc.
Address:
One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States (US)

Name:
Amgen Research (Munich) GmbH
Address:
Staffelseestrasse 2, 81477 München, Germany (DE)

Agent

Name:
ARONOVA S.A.
From:
12/03/2019
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
KUFER, Peter
Address:
Germany (DE)

2

Name:
ZUGMAIER, Gerhard
Address:
Germany (DE)

3

Name:
ALEKAR, Shilpa
Address:
United States (US)

Priority

Priority Number:
201462005560 P
Priority Date:
30/05/2014
Priority Country:
United States (US)

Classification

IPC classification:
G01N 33/574;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2021/12
Publication date:
04/11/2021
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

1

Issue number:
201852
Publication date:
26/12/2018
Description:
Grant (B1)

2

Issue number:
201904
Publication date:
23/01/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202142
Publication date:
20/10/2021
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
10/05/2021
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
19/03/2019 Outgoing Correspondence 1
12/03/2019 Power Of Attorney 1